Terms: = Lung cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Staging
193 results:
1. TIMM17A overexpression in lung adenocarcinoma and its association with prognosis.
Miao L; Wu D; Zhao H; Xie A
Sci Rep; 2024 Apr; 14(1):8840. PubMed ID: 38632467
[TBL] [Abstract] [Full Text] [Related]
2. Predictors of cancer-specific survival and overall survival among patients aged ≥60 years with lung adenocarcinoma using the SEER database.
Li F; Li F; Zhao D; Lu H
J Int Med Res; 2024 Apr; 52(4):3000605241240993. PubMed ID: 38606733
[TBL] [Abstract] [Full Text] [Related]
3. Novel Functional Radiomics for Prediction of Cardiac Positron Emission Tomography Avidity in lung cancer Radiotherapy.
Choi W; Jia Y; Kwak J; Werner-Wasik M; Dicker AP; Simone NL; Storozynsky E; Jain V; Vinogradskiy Y
JCO Clin Cancer Inform; 2024 Mar; 8():e2300241. PubMed ID: 38452302
[TBL] [Abstract] [Full Text] [Related]
4. A novel investigation into the negative impact of opioid use on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients.
Guo H; Li Y; Lin J; Li D; Yang J; Wang J; Mao J; Wang Y; Yan X
Int Immunopharmacol; 2024 Mar; 129():111611. PubMed ID: 38325047
[TBL] [Abstract] [Full Text] [Related]
5. Head-to-head comparison of
Zhang M; Liu Z; Yuan Y; Yang W; Cao X; Ma M; Han B
Diagn Interv Radiol; 2024 Mar; 30(2):99-106. PubMed ID: 38291975
[TBL] [Abstract] [Full Text] [Related]
6. Spatial features of specific CD103
Yang G; Cai S; Hu M; Li C; Yang L; Zhang W; Sun J; Sun F; Xing L; Sun X
J Transl Med; 2024 Jan; 22(1):27. PubMed ID: 38183111
[TBL] [Abstract] [Full Text] [Related]
7. Construction and validation of a nomogram to predict the overall survival of small cell lung cancer: a multicenter retrospective study in Shandong province, China.
Song Z; Ma H; Sun H; Li Q; Liu Y; Xie J; Feng Y; Shang Y; Ma K; Zhang N; Wang J
BMC Cancer; 2023 Dec; 23(1):1182. PubMed ID: 38041067
[TBL] [Abstract] [Full Text] [Related]
8. Clinical Significance of the Proposed Pathologic Criteria for Invasion by the International Association for the Study of lung cancer in Resected Nonmucinous lung Adenocarcinoma.
Hong TH; Hwang S; Cho J; Choi YL; Han J; Lee G; Jeon YJ; Lee J; Park SY; Cho JH; Choi YS; Kim J; Shim YM; Kim HK
J Thorac Oncol; 2024 Mar; 19(3):425-433. PubMed ID: 37924973
[TBL] [Abstract] [Full Text] [Related]
9. Development and Validation of Prognostic Nomograms for lung Squamous Cell Carcinoma With Brain Metastasis in Patients Aged 45 Years or Older: A Population-Based Study.
Yang F; Gao L; Wang Q; Gao W
Cancer Control; 2023; 30():10732748231202953. PubMed ID: 37776257
[TBL] [Abstract] [Full Text] [Related]
10. The International Association for the Study of lung cancer Thymic Epithelial Tumors staging Project: Proposal for a Stage Classification for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors.
Ruffini E; Huang J; Cilento V; Goren E; Detterbeck F; Ahmad U; Appel S; Bille A; Boubia S; Brambilla C; Cangir AK; Falkson C; Fang W; Filosso PL; Giaccone G; Girard N; Guerrera F; Infante M; Kim DK; Lucchi M; Marino M; Marom EM; Nicholson AG; Okumura M; Rami-Porta R; Rimner A; Simone CB; Asamura H;
J Thorac Oncol; 2023 Dec; 18(12):1655-1671. PubMed ID: 37689391
[TBL] [Abstract] [Full Text] [Related]
11. The International Association for the Study of lung cancer Thymic Epithelial Tumor staging Project: A Re-Assessment of the International Thymic Malignancy Interest Group/International Association for the Study of lung cancer Lymph Node Map for Thymic Epithelial Tumors for the Forthcoming Ninth Edition of the TNM Classification of Malignant Tumors.
Marom EM; Fang W; Ruffini E; Detterbeck F; Ahmad U; Appel S; Bille A; Boubia S; Brambilla C; Cilento V; Cangir AK; Falkson C; Filosso PL; Giaccone G; Girard N; Goren E; Guerrera F; Huang J; Infante M; Kim DK; Lucchi M; Marino M; Nicholson AG; Okumura M; Rami-Porta R; Rimner A; Simone CB; Asamura H;
J Thorac Oncol; 2023 Dec; 18(12):1672-1688. PubMed ID: 37689390
[TBL] [Abstract] [Full Text] [Related]
12. The International Association for the Study of lung cancer Pleural Mesothelioma staging Project: Updated Modeling of Prognostic Factors in Pleural Mesothelioma.
Wolf AS; Rosenthal A; Giroux DJ; Nowak AK; Bille A; de Perrot M; Kindler HL; Rice D; Opitz I; Rusch VW; Pass HI; ;
J Thorac Oncol; 2023 Dec; 18(12):1689-1702. PubMed ID: 37567386
[TBL] [Abstract] [Full Text] [Related]
13. Diagnostic potential of [
Zhang M; Yang W; Yuan Y; Liu Z; Yue X; Cao X; Han B
Jpn J Radiol; 2024 Jan; 42(1):87-95. PubMed ID: 37566187
[TBL] [Abstract] [Full Text] [Related]
14. A radiomics nomogram prediction for survival of patients with "driver gene-negative" lung adenocarcinomas (LUAD).
Guo QK; Yang HS; Shan SC; Chang DD; Qiu LJ; Luo HH; Li HP; Ke ZF; Zhu Y
Radiol Med; 2023 Jun; 128(6):714-725. PubMed ID: 37219740
[TBL] [Abstract] [Full Text] [Related]
15. Closing the Testing Gap: Standardization of Comprehensive Biomarker Testing for Metastatic Non-Small-Cell lung cancer in a Large Community Oncology Practice.
Waterhouse DM; Ward P; Arnal S; Neubauer M; Drosick DR; Davies D; Mendenhall MA
JCO Oncol Pract; 2023 Jun; 19(6):e951-e956. PubMed ID: 37126768
[TBL] [Abstract] [Full Text] [Related]
16. Multi-task learning-based histologic subtype classification of non-small cell lung cancer.
Chen K; Wang M; Song Z
Radiol Med; 2023 May; 128(5):537-543. PubMed ID: 36976403
[TBL] [Abstract] [Full Text] [Related]
17. Pretherapy investigations using highly robust visualized biomarkers from CT imaging by multiple machine-learning techniques toward its prognosis prediction for ALK-inhibitor therapy in NSCLC: a feasibility study.
Sun J; Li F; Yang J; Lin C; Zhou X; Liu N; Zhang B; Song G; Wang W; Huang C; Song Z; Shi L
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7341-7353. PubMed ID: 36928998
[TBL] [Abstract] [Full Text] [Related]
18. Integrated analyzes identify CCT3 as a modulator to shape immunosuppressive tumor microenvironment in lung adenocarcinoma.
Huang J; Hu B; Yang Y; Liu H; Fan X; Zhou J; Chen L
BMC Cancer; 2023 Mar; 23(1):241. PubMed ID: 36918801
[TBL] [Abstract] [Full Text] [Related]
19. Implications for surveillance for breast cancer patients based on the internally and externally validated BRENDA-metastatic recurrence score.
Ebner F; Salmen J; Dayan D; Kiesel M; Wolters R; Janni W; Wöckel A; Wischnewsky M
Breast Cancer Res Treat; 2023 May; 199(1):173-184. PubMed ID: 36917303
[TBL] [Abstract] [Full Text] [Related]
20. Classification of Histological Types and Stages in Non-small Cell lung cancer Using Radiomic Features Based on CT Images.
Lin J; Yu Y; Zhang X; Wang Z; Li S
J Digit Imaging; 2023 Jun; 36(3):1029-1037. PubMed ID: 36828962
[TBL] [Abstract] [Full Text] [Related]
[Next]
